Develops cancer drugs.
Dec 2023Revenue $5.00M/yrExpenses $77.6M/yr
No trendCash runway ≈ 1.2 years from Dec 2024
Figures by year
When will Adlai Nortye Group be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2023, revenue was $5.00M and expenses $77.6M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2023 | $5.00M | $77.6M | −$72.6M |
| Dec 2021 | $45.7M | $54.4M | −$8.65M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.